Aetna
Dr. Noble Ezukanma, MD
Pulmonary Disease*
Age 67
Be the first to review this provider!
Dr. Noble Ezukanma, MD
Be the first to review this provider!
Fort Worth, TX
Accepting new patients
Clinical Overview
Dr. Noble Ezukanma, MD works in Fort Worth, TX as
COMPARE OTHER TOP Pulmonologists
Contrast Dr. Ezukanma with other nearby specialists practicing at Medical City Dallas Hospital.
Make an appointment at Medical City Dallas Hospital today at 972-456-9314.
Make an appointment at Medical City Dallas Hospital today at 972-456-9314.
These providers are on the medical staff of Medical City Dallas Hospital.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Cigna
-
Humana
-
MultiPlan
-
HealthStar
-
Medicaid
-
Commercial Insurance Company
-
Tricare
-
Coventry Health Care
-
Assurant Health
-
Medicare
-
PacifiCare Health Systems
-
Pacific Mutual
-
Golden Rule
-
United Healthcare
Office Locations
-
Office508 S Adams St Ste 218, Fort Worth, TX 76104
-
Office8401 Jacksboro Hwy Ste 218, Lakeside, TX 76135
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Ezukanma?
Step 1 of 3
Your review of Dr. Noble Ezukanma, MD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Languages Spoken
Spanish
Specialties*
Internal Medicine
Pulmonary Disease
Critical Care Medicine
Cardiovascular & Pulmonary Diseases
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Noble Ezukanma, MD accepts new patients on Medical News Today.
Dr. Ezukanma accepts Medicare, Medicaid, Aetna, Cigna, Humana, MultiPlan, HealthStar, Commercial Insurance Company, Tricare, Coventry Health Care, Assurant Health, PacifiCare Health Systems, Pacific Mutual, Golden Rule and UnitedHealthCare as well as many others.
Dr. Ezukanma's office is located at 508 S Adams St Ste 218 Fort Worth, TX 76104. Get a map and directions to Dr. Ezukanma's office here.
Yes, Dr. Ezukanma speaks Spanish. See Dr. Ezukanma's profile on MedicalNewsToday for more information.
Dr. Ezukanma does not have any reviews yet.
Education & Credentials
Medical Education
- Universidad Central del Este Escuela de Medicina
Residency Hospital
-
St Francis Medical Center
1992
Claim Your Profile
Are you Dr. Noble Ezukanma, MD?
Affiliated Hospitals & Medical Centers
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A drug candidate created with AI reduced biological age markers across 6 proteomic clocks in a phase 2a trial, suggesting that it may help reverse predicted biological aging.
A recent study has found that elevated NT-proBNP levels could help predict the risk of heart disease in older adults. Experts weigh in on whether the test could eventually have a role in routine cardiovascular risk assessment.
Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the treatment of lung cancer in early trials.
